|
1F16
SOLUTION STRUCTURE OF A PRO-APOPTOTIC PROTEIN BAX
Deposited 2000-05-18
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–192(192 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;305 K;Ionic strength (raw mmCIF value) 10 mM;Pressure AMBIENT
NMR sample composition
1MM BAX U-15N,13C; 10mM TRIS-ACETATE PH 6.0 2MM DTT
|
Resolution not provided
|
|
2K7W
BAX Activation is Initiated at a Novel Interaction Site
Deposited 2008-08-27
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–192(192 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;305 K;Ionic strength (raw mmCIF value) 50;Pressure ambient
NMR sample composition
0.1-0.2 mM [U-99% 15N] protein, 0.1-0.2 mM peptide, 90% H2O/10%D20 | 90% H2O/10%D20
|
Resolution not provided
|
|
2LR1
Structural Mechanism for Bax Inhibition by Cytomegalovirus Protein vMIA
Deposited 2012-03-20
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–192(192 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.2;310 K;Ionic strength (raw mmCIF value) 50;Pressure ambient
NMR sample composition
0.1 mM protein_1, 0.1 mM [U-100% 13C; U-100% 15N] protein_2, 20 mM potassium phosphate, 5 M [U-100% 2H] D2O, 50 M H2O, DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.1 mM [U-100% 15N] protein_1, 0.1 mM protein_2, 20 mM potassium phosphate, 5 M [U-100% 2H] D2O, 50 M H2O, DTT, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
3PK1
Crystal structure of Mcl-1 in complex with the BaxBH3 domain
Deposited 2010-11-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
48–81(34 aa)
Fragment:BH3 domain, UNP residues 48-81
|
Not recorded
|
CD CADMIUM ION × 10
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;1M Sodium Acetate, 0.1M Hepes, 25mM Cadmium Sulfate, 5mM TCEP, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.49 Å
R-free 0.245
|
|
3PK1
Crystal structure of Mcl-1 in complex with the BaxBH3 domain
Deposited 2010-11-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
48–81(34 aa)
Fragment:BH3 domain, UNP residues 48-81
|
Not recorded
|
CD CADMIUM ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;1M Sodium Acetate, 0.1M Hepes, 25mM Cadmium Sulfate, 5mM TCEP, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.49 Å
R-free 0.245
|
|
3PL7
Crystal structure of Bcl-xL in complex with the BaxBH3 domain
Deposited 2010-11-14
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
48–81(34 aa)
Fragment:BH3 domain, UNP residues 48-81
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;293 K;13% Peg 6000, 0.2M CaCl2, 0.1M Tris, pH 8.0, VAPOR DIFFUSION, temperature 293K
|
Resolution 2.61 Å
R-free 0.249
|
|
4BD2
Bax domain swapped dimer in complex with BidBH3
Deposited 2012-10-04
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–171(171 aa)
Fragment:RESIDUES 1-171
|
Mutation:YES
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.4 M SODIUM CITRATE, 0.1 M SODIUM CACODYLATE PH 5.75
|
Resolution 2.21 Å
R-free 0.227
|
|
4BD6
Bax domain swapped dimer in complex with BaxBH3
Deposited 2012-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–171(171 aa)
Fragment:RESIDUES 1-171
Chain C
48–81(34 aa)
Fragment:RESIDUES 48-81
|
Mutation:YES
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.4 M SODIUM CITRATE, 0.1 M SODIUM CACODYLATE PH 5.75
|
Resolution 2.49 Å
R-free 0.285
|
|
4BD7
Bax domain swapped dimer induced by octylmaltoside
Deposited 2012-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–171(171 aa)
Fragment:RESIDUES 1-171
Chain B
1–171(171 aa)
Fragment:RESIDUES 1-171
|
Mutation:YES
Mutation:YES
|
PR PRASEODYMIUM ION × 2
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8 M NH4SO4, 0.1 M HEPES PH 6.5, 10 MM PRCL3
|
Resolution 2.80 Å
R-free 0.274
|
|
4BD7
Bax domain swapped dimer induced by octylmaltoside
Deposited 2012-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–171(171 aa)
Fragment:RESIDUES 1-171
Chain D
1–171(171 aa)
Fragment:RESIDUES 1-171
|
Mutation:YES
Mutation:YES
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8 M NH4SO4, 0.1 M HEPES PH 6.5, 10 MM PRCL3
|
Resolution 2.80 Å
R-free 0.274
|
|
4BD8
Bax domain swapped dimer induced by BimBH3 with CHAPS
Deposited 2012-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–171(171 aa)
Fragment:RESIDUES 1-171
Chain B
1–171(171 aa)
Fragment:RESIDUES 1-171
|
Mutation:YES
Mutation:YES
|
PR PRASEODYMIUM ION × 2
EDO 1,2-ETHANEDIOL × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8 M NH4SO4, 0.1 M HEPES PH 6.5, 10 MM PRCL3
|
Resolution 2.22 Å
R-free 0.256
|
|
4BD8
Bax domain swapped dimer induced by BimBH3 with CHAPS
Deposited 2012-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–171(171 aa)
Fragment:RESIDUES 1-171
Chain D
1–171(171 aa)
Fragment:RESIDUES 1-171
|
Mutation:YES
Mutation:YES
|
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
1.8 M NH4SO4, 0.1 M HEPES PH 6.5, 10 MM PRCL3
|
Resolution 2.22 Å
R-free 0.256
|
|
4BDU
Bax BH3-in-Groove dimer (GFP)
Deposited 2012-10-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
53–128(76 aa)
Fragment:BAX RESIDUES 53-128
Chain B
53–128(76 aa)
Fragment:BAX RESIDUES 53-128
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
10% PEG3350, 20% MPD, 0.5% CHAPS, 0.1 M TRIS PH 8.0
|
Resolution 3.00 Å
R-free 0.246
|
|
4BDU
Bax BH3-in-Groove dimer (GFP)
Deposited 2012-10-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain C
53–128(76 aa)
Fragment:BAX RESIDUES 53-128
Chain D
53–128(76 aa)
Fragment:BAX RESIDUES 53-128
|
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:YES
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
10% PEG3350, 20% MPD, 0.5% CHAPS, 0.1 M TRIS PH 8.0
|
Resolution 3.00 Å
R-free 0.246
|
|
4S0O
Crystal Structure of the Autoinhibited Dimer of Pro-apoptotic BAX (I)
Deposited 2015-01-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–192(192 aa)
Chain B
1–192(192 aa)
|
Mutation:P168G
Mutation:P168G
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;1.6 M AMMONIUM SULFATE, 0.1 M BIS-TRIS , PH 6.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
|
Resolution 1.90 Å
R-free 0.265
|
|
4S0P
Crystal Structure of the Autoinhibited Dimer of Pro-apoptotic BAX (II)
Deposited 2015-01-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–192(192 aa)
|
Mutation:G67R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;1.6 M AMMONIUM SULFATE, 0.1 M BIS-TRIS, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.25 Å
R-free 0.270
|
|
4S0P
Crystal Structure of the Autoinhibited Dimer of Pro-apoptotic BAX (II)
Deposited 2015-01-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–192(192 aa)
|
Mutation:G67R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.2;293 K;1.6 M AMMONIUM SULFATE, 0.1 M BIS-TRIS, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.25 Å
R-free 0.270
|
|
4ZIE
Crystal Structure of core/latch dimer of Bax in complex with BimBH3
Deposited 2015-04-28
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–166(166 aa)
|
Mutation:C62S C126S
|
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 9;277 K;PEG6000, bicine
|
Resolution 1.80 Å
R-free 0.229
|
|
4ZIF
Crystal Structure of core/latch dimer of Bax in complex with BimBH3mini
Deposited 2015-04-28
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–166(166 aa)
|
Mutation:C62S C126S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Tri-sodium citrate, Sodium cacodylate
|
Resolution 2.40 Å
R-free 0.255
|
|
4ZIG
Crystal Structure of core/latch dimer of Bax in complex with BidBH3mini
Deposited 2015-04-28
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–166(166 aa)
|
Mutation:C62S, C126S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Tri-sodium citrate, Sodium cacodylate
|
Resolution 2.20 Å
R-free 0.229
|
|
4ZIH
Crystal Structure of core/latch dimer of Bax in complex with BimBH3mini
Deposited 2015-04-28
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–164(164 aa)
|
Mutation:C62S, C126S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Tri-sodium citrate, Sodium cacodylate
|
Resolution 2.50 Å
R-free 0.233
|
|
4ZII
Crystal Structure of core/latch dimer of BaxI66A in complex with BidBH3
Deposited 2015-04-28
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–170(170 aa)
|
Mutation:C62S, C126S
|
EDO 1,2-ETHANEDIOL × 10
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Tri-sodium citrate, sodium cacodylate
|
Resolution 2.19 Å
R-free 0.223
|
|
5W5X
Crystal structure of BAXP168G in complex with an activating antibody
Deposited 2017-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–192(192 aa)
|
Mutation:C62S C126S P168G
|
EDO 1,2-ETHANEDIOL × 9
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 4000, HEPES
|
Resolution 2.50 Å
R-free 0.243
|
|
5W5X
Crystal structure of BAXP168G in complex with an activating antibody
Deposited 2017-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–192(192 aa)
|
Mutation:C62S C126S P168G
|
EDO 1,2-ETHANEDIOL × 18
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;PEG 4000, HEPES
|
Resolution 2.50 Å
R-free 0.243
|
|
5W5Z
Crystal structure of BAXP168G in complex with an activating antibody at high resolution
Deposited 2017-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
32–192(161 aa)
Fragment:UNP residues 32-192
|
Mutation:C62S C126S P168G
|
EDO 1,2-ETHANEDIOL × 3
PG4 TETRAETHYLENE GLYCOL × 2
PGE TRIETHYLENE GLYCOL × 2
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;Peg4000, MES
|
Resolution 2.00 Å
R-free 0.268
|
|
5W60
Crystal structure of BAXP168G monomer cryo-protected with ethylene glycol
Deposited 2017-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–192(192 aa)
|
Mutation:C62S C126S P168G
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;Ammonium sulfate, TRIS
|
Resolution 1.80 Å
R-free 0.238
|
|
5W61
Crystal structure of BAXP168G monomer co-crystallized with glycerol
Deposited 2017-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–192(192 aa)
|
Mutation:C62S C126S P168G
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;Ammonium sulfate, bis-TRIS, glycerol
|
Resolution 2.30 Å
R-free 0.252
|
|
6EB6
Crystal structure of BAX W139A monomer
Deposited 2018-08-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–192(192 aa)
|
Mutation:W139A
|
FMT FORMIC ACID × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Sodium formate, TCEP
|
Resolution 2.02 Å
R-free 0.201
|
|
6L8V
membrane-bound Bax helix2-helix5 domain
Deposited 2019-11-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
|
Mutation:C62S, C126S
Mutation:C62S, C126S
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;305 K;Ionic strength (raw mmCIF value) 100;Pressure 1
NMR sample composition
0.5 mM U-98% 15N;U-98% 13C;U-98% 2H human Bax core domain, 100 mM DMPC, 140 mM DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6 mM U-98% 15N;U-98% 13C Bax a_2_a_5, 100 mM [U-2H] DMPC, 160 mM [U-2H] DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.4 mM U-98% 15N;U-2H Bax a_2_a_5, 120 mM [U-2H] DMPC, 200 mM [U-2H] DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6 mM U-98% 15N;U-2H Bax a_2_a_5, 100 mM DMPC, 160 mM [U-2H] DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.4 mM U-98% 15N;U-15% 13C Bax a_2_a_5, 80 mM DMPC, 140 mM DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.4 mM U-98% 13C Bax a_2_a_5, 120 mM [U-2H] DMPC, 200 mM [U-2H] DHPC, 10 mM MES, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
6L95
transmembrane-domain of Bax
Deposited 2019-11-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
166–192(27 aa)
Chain B
166–192(27 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.5;298 K;Ionic strength (raw mmCIF value) 150;Pressure 1
NMR sample composition
0.6 mM [U-98% 15N;U-98% 13C;U-98% 2H] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6 mM [U-98% 15N;U-98% 13C] human bax helix9, 0.1 % [U-2H] DPC, 25 mM HEPES, 150 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.3 mM [U-98% 15N;U-2H] human bax helix9, 0.1 % [U-2H] DPC, 25 mM HEPES, 150 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.4 mM [U-98% 15N;U-15% 13C] human bax helix9, 0.1 % DPC, 25 mM HEPES, 150 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.3 mM [U-98% 13C] human bax helix9, 0.1 % [U-2H] DPC, 25 mM HEPES, 150 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
6TRR
Structural insight into tanapoxvirus mediated inhibition of apoptosis
Deposited 2019-12-19
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
50–77(28 aa)
|
Not recorded
|
NA SODIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium Chloride, 0.1 M Citrate pH 4.0
20% PEG 6000
|
Resolution 2.12 Å
R-free 0.254
|
|
6XY6
Structural insight into sheep-pox virus mediated inhibition of apoptosis
Deposited 2020-01-29
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
50–77(28 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å
R-free 0.288
|
|
6XY6
Structural insight into sheep-pox virus mediated inhibition of apoptosis
Deposited 2020-01-29
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
50–77(28 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å
R-free 0.288
|
|
6XY6
Structural insight into sheep-pox virus mediated inhibition of apoptosis
Deposited 2020-01-29
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
50–77(28 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å
R-free 0.288
|
|
6XY6
Structural insight into sheep-pox virus mediated inhibition of apoptosis
Deposited 2020-01-29
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
50–77(28 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å
R-free 0.288
|
|
6XY6
Structural insight into sheep-pox virus mediated inhibition of apoptosis
Deposited 2020-01-29
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain J
50–77(28 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å
R-free 0.288
|
|
6XY6
Structural insight into sheep-pox virus mediated inhibition of apoptosis
Deposited 2020-01-29
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
50–77(28 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å
R-free 0.288
|
|
6XY6
Structural insight into sheep-pox virus mediated inhibition of apoptosis
Deposited 2020-01-29
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 7
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain N
50–77(28 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å
R-free 0.288
|
|
6XY6
Structural insight into sheep-pox virus mediated inhibition of apoptosis
Deposited 2020-01-29
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 8
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain P
50–77(28 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;1.0 M Lithium chloride, 0.1 M Citrate pH 4.0, 20% w/vPEG 6000
|
Resolution 2.91 Å
R-free 0.288
|
|
7ADT
Orf virus Apoptosis inhibitor ORFV125
Deposited 2020-09-16
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
50–77(28 aa)
Chain U
50–77(28 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 7
GOL GLYCEROL × 2
MG MAGNESIUM ION × 41
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.2 M Magnesium chloride hexahydrate, 0.1 M Bis-Tris pH 5.5, 25% PEG 3350
|
Resolution 2.21 Å
R-free 0.259
|
|
8G1T
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P21
Deposited 2023-02-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.44 M sodium citrate, 0.01 M TCEP
|
Resolution 2.09 Å
R-free 0.248
|
|
8G1T
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P21
Deposited 2023-02-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
53–128(76 aa)
Chain D
53–128(76 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.44 M sodium citrate, 0.01 M TCEP
|
Resolution 2.09 Å
R-free 0.248
|
|
8G1T
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P21
Deposited 2023-02-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain E
53–128(76 aa)
Chain F
53–128(76 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.44 M sodium citrate, 0.01 M TCEP
|
Resolution 2.09 Å
R-free 0.248
|
|
8G1T
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P21
Deposited 2023-02-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain G
53–128(76 aa)
Chain H
53–128(76 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.44 M sodium citrate, 0.01 M TCEP
|
Resolution 2.09 Å
R-free 0.248
|
|
8SPE
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31
Deposited 2023-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
Chain C
53–128(76 aa)
Chain D
53–128(76 aa)
|
Not recorded
|
ZN ZINC ION × 4
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å
R-free 0.256
|
|
8SPE
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31
Deposited 2023-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain Q
53–128(76 aa)
Chain R
53–128(76 aa)
Chain S
53–128(76 aa)
Chain T
53–128(76 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å
R-free 0.256
|
|
8SPE
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31
Deposited 2023-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain G
53–128(76 aa)
Chain H
53–128(76 aa)
Chain U
53–128(76 aa)
Chain V
53–128(76 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å
R-free 0.256
|
|
8SPE
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31
Deposited 2023-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain E
53–128(76 aa)
Chain F
53–128(76 aa)
Chain I
53–128(76 aa)
Chain J
53–128(76 aa)
|
Not recorded
|
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 3
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å
R-free 0.256
|
|
8SPE
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31
Deposited 2023-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain K
53–128(76 aa)
Chain L
53–128(76 aa)
Chain M
53–128(76 aa)
Chain N
53–128(76 aa)
|
Not recorded
|
ZN ZINC ION × 1
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å
R-free 0.256
|
|
8SPE
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31
Deposited 2023-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain O
53–128(76 aa)
Chain P
53–128(76 aa)
Chain W
53–128(76 aa)
Chain X
53–128(76 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å
R-free 0.256
|
|
8SPE
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31
Deposited 2023-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 7
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain Y
53–128(76 aa)
Chain Z
53–128(76 aa)
Chain a
53–128(76 aa)
Chain b
53–128(76 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å
R-free 0.256
|
|
8SPE
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31
Deposited 2023-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 8
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain c
53–128(76 aa)
Chain d
53–128(76 aa)
Chain e
53–128(76 aa)
Chain f
53–128(76 aa)
|
Not recorded
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å
R-free 0.256
|
|
8SPE
Crystal structure of Bax core domain BH3-groove dimer - tetrameric fraction P31
Deposited 2023-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 9
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain g
53–128(76 aa)
Chain h
53–128(76 aa)
Chain i
53–128(76 aa)
Chain j
53–128(76 aa)
|
Not recorded
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M NaMES pH 5.6, 27% PEG MME550, 0.01 M Zinc sulfate
|
Resolution 2.30 Å
R-free 0.256
|
|
8SPF
Crystal structure of Bax core domain BH3-groove dimer - hexameric fraction with 2-stearoyl lysoPC
Deposited 2023-05-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 6
PDB declaration: hexameric
|
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
Chain C
53–128(76 aa)
Chain D
53–128(76 aa)
Chain E
53–128(76 aa)
Chain F
53–128(76 aa)
|
Not recorded
|
1GP SN-GLYCEROL-1-PHOSPHATE × 1
EDO 1,2-ETHANEDIOL × 5
OCT N-OCTANE × 1
D12 DODECANE × 1
DD9 nonane × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.1 M Hepes pH 7.5, 1.4 M trisodium citrate
|
Resolution 2.20 Å
R-free 0.305
|
|
8SPZ
Crystal structure of Bax core domain BH3-groove dimer - hexameric fraction with dioctanoyl phosphatidylserine
Deposited 2023-05-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.09 M DL maleate-MES-Tris pH 7, 2.25 M ammonium sulfate, 0.1 M trisodium citrate
|
Resolution 2.40 Å
R-free 0.341
|
|
8SPZ
Crystal structure of Bax core domain BH3-groove dimer - hexameric fraction with dioctanoyl phosphatidylserine
Deposited 2023-05-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
53–128(76 aa)
Chain D
53–128(76 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;0.09 M DL maleate-MES-Tris pH 7, 2.25 M ammonium sulfate, 0.1 M trisodium citrate
|
Resolution 2.40 Å
R-free 0.341
|
|
8SRX
Crystal structure of BAK-BAX heterodimer with lysoPC
Deposited 2023-05-07
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
53–128(76 aa)
Chain D
53–128(76 aa)
|
Not recorded
|
K6G [(2~{R})-2-oxidanyl-3-[oxidanyl-[2-(trimethyl-$l^{4}-azanyl)ethoxy]phosphoryl]oxy-propyl] hexadecanoate × 3
ZN ZINC ION × 1
NA SODIUM ION × 2
PEG DI(HYDROXYETHYL)ETHER × 2
EDO 1,2-ETHANEDIOL × 2
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;281 K;0.1 M Bis-tris chloride pH 5.5, 25% PEG 3350, 200 mM sodium acetate
|
Resolution 2.09 Å
R-free 0.265
|
|
8SRY
Crystal structure of BAK-BAX heterodimer with C12E8
Deposited 2023-05-08
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
53–128(76 aa)
Chain D
53–128(76 aa)
|
Not recorded
|
PG0 2-(2-METHOXYETHOXY)ETHANOL × 1
PEG DI(HYDROXYETHYL)ETHER × 2
N8E 3,6,9,12,15-PENTAOXATRICOSAN-1-OL × 1
P33 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL × 1
PG4 TETRAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;281 K;30% PEG MME 2000, 0.1 M potassium thiocyanate, 0.01% C12E8
|
Resolution 2.40 Å
R-free 0.248
|
|
8SVK
Crystal structure of Bax D71N core domain BH3-groove dimer
Deposited 2023-05-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
53–128(76 aa)
Chain B
53–128(76 aa)
|
Mutation:C62S, D71N, C126S
Mutation:C62S, D71N, C126S
|
PEG DI(HYDROXYETHYL)ETHER × 2
PGE TRIETHYLENE GLYCOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M sodium citrate, 20% PEG 3350
|
Resolution 2.25 Å
R-free 0.287
|
|
8SVK
Crystal structure of Bax D71N core domain BH3-groove dimer
Deposited 2023-05-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain C
53–128(76 aa)
Chain D
53–128(76 aa)
|
Mutation:C62S, D71N, C126S
Mutation:C62S, D71N, C126S
|
PEG DI(HYDROXYETHYL)ETHER × 1
PGE TRIETHYLENE GLYCOL × 1
PG4 TETRAETHYLENE GLYCOL × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M sodium citrate, 20% PEG 3350
|
Resolution 2.25 Å
R-free 0.287
|
|
9IXU
Overall reconstruction of the Bax line
Deposited 2024-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
1–192(192 aa)
Chain B
1–192(192 aa)
Chain C
1–192(192 aa)
Chain D
1–192(192 aa)
Chain E
1–192(192 aa)
Chain F
1–192(192 aa)
Chain G
1–192(192 aa)
Chain H
1–192(192 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.19 Å
|